Aktienanalyse zu Gyrodyne LLC (GYRO)

KI-Analyse of Gyrodyne LLC (GYRO)

Halten

Gyrodyne LLC (GYRO) is currently trading at $4.00, which is significantly below its 52-week high of $9.71, indicating potential for recovery. However, the stock has seen a year-to-date decline of 55.85% and a 20-day change of -15.07%, suggesting ongoing weakness. The RSI is extremely low at 8.117, indicating the stock is oversold, but this could also reflect deeper issues. The forward P/E ratio is 0, indicating no earnings expectations, which is a red flag. Given these factors, while there is potential upside, the significant risks outweigh the current buying opportunity, making it prudent to hold rather than buy.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Gyrodyne LLC (GYRO) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.

Erwartetes KGV

Stark unterbewertet

5J-Durchschnitt P/E

0.00

Aktuelles P/E

0.00

Überbewertet

0.00

Unterbewertet

0.00

Erwartetes EV/EBITDA

Stark unterbewertet

5J-Durchschnitt EV/EBITDA

0.00

Aktuelles EV/EBITDA

0.00

Überbewertet

0.00

Unterbewertet

0.00

Erwartetes KUV

Fair bewertet

5J-Durchschnitt P/S

0.12

Aktuelles P/S

0.00

Überbewertet

1.17

Unterbewertet

-0.94

Alphio-AI-Kursszenarien für GYRO

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%GYRO

$9.32

Szenariopreis

B

Basis

Basis · 50%GYRO

$7.82

Szenariopreis

B

Bärisch

Bärisch · 25%GYRO

$6.16

Szenariopreis

GYRO FAQ – beantwortet von Alphio AI

Gyrodyne, LLC owns and manages diverse commercial properties. The Company’s primary business is the management of a portfolio of medical office and industrial properties and the pursuit of entitlements on such properties located in Suffolk (Flowerfield) and Westchester (Cortlandt Manor) Counties, New York. The Company owns about a 63-acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York. In Cortlandt Manor, New York, the Company owns about 13.8 acres inclusive of the 31,421-square-foot Cortlandt Medical Center. It operates in the Real Estate sector (OPERATORS OF NONRESIDENTIAL BUILDINGS industry).

Gyrodyne LLC (GYRO) is currently trading at $4.00, which is significantly below its 52-week high of $9.71, indicating potential for recovery. However, the stock has seen a year-to-date decline of 55.85% and a 20-day change of -15.07%, suggesting ongoing weakness. The RSI is extremely low at 8.117, indicating the stock is oversold, but this could also reflect deeper issues. The forward P/E ratio is 0, indicating no earnings expectations, which is a red flag. Given these factors, while there is potential upside, the significant risks outweigh the current buying opportunity, making it prudent to hold rather than buy.